Taysha Gene Therapies, Inc. (TSHA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$110.50M | -20.8% |
| 2024 | -$91.46M | -26.3% |
| 2023 | -$72.44M | +55.4% |
| 2022 | -$162.45M | +6.2% |
| 2021 | -$173.27M | -302.9% |
| 2020 | -$43.00M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$110.50M | -20.8% |
| 2024 | -$91.46M | -26.3% |
| 2023 | -$72.44M | +55.4% |
| 2022 | -$162.45M | +6.2% |
| 2021 | -$173.27M | -302.9% |
| 2020 | -$43.00M | — |